Cinti, F., Leccisotti, L., Sorice, G. P., Capece, U., D’Amario, D., Lorusso, M., . . . Giaccari, A. (2023, December). Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovascular Diabetology.
Chicagoスタイル(17版)引用形式Cinti, Francesca, et al. "Dapagliflozin Treatment Is Associated with a Reduction of Epicardial Adipose Tissue Thickness and Epicardial Glucose Uptake in Human Type 2 Diabetes." Cardiovascular Diabetology Dec. 2023.
MLA(9版)引用形式Cinti, Francesca, et al. "Dapagliflozin Treatment Is Associated with a Reduction of Epicardial Adipose Tissue Thickness and Epicardial Glucose Uptake in Human Type 2 Diabetes." Cardiovascular Diabetology, Dec. 2023.